1. Home
  2. PGY vs NEO Comparison

PGY vs NEO Comparison

Compare PGY & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$12.73

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGY
NEO
Founded
2016
2001
Country
United States
United States
Employees
511
N/A
Industry
Finance: Consumer Services
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
PGY
NEO
Price
$12.73
$9.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
8
Target Price
$34.50
$13.38
AVG Volume (30 Days)
3.5M
2.0M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.27
$10.63
Revenue Next Year
$14.39
$9.73
P/E Ratio
$13.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.40
$4.72
52 Week High
$44.99
$13.74

Technical Indicators

Market Signals
Indicator
PGY
NEO
Relative Strength Index (RSI) 43.68 60.46
Support Level $10.78 $7.42
Resistance Level $15.57 $10.82
Average True Range (ATR) 0.89 0.40
MACD -0.21 0.04
Stochastic Oscillator 12.12 89.45

Price Performance

Historical Comparison
PGY
NEO

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: